Literature DB >> 20668374

Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation.

Timothy M Connolly1, Hayden Eastwood, Gordana Kel, Halina Lisnichuk, Rachael Richardson, Stephen O'Leary.   

Abstract

AIM: To protect hearing during cochlear implantation with systemic administration of dexamethasone.
METHODS: Seventeen normal-hearing guinea pigs were randomly allocated to receive an intravenous injection of either normal saline (control), low- (0.2 mg/kg) or high- (2 mg/kg) dose dexamethasone 60 min prior to cochlear implantation. Auditory brainstem response (ABR) threshold shifts (2-32 kHz) were estimated between pre- and 4-week-postoperative levels.
RESULTS: ABR threshold shifts (8-32 kHz) observed in control and low-dose steroid groups were significantly reduced in the high-dose steroid group.
CONCLUSIONS: A single, high-dose injection of intravenous dexamethasone protected hearing during cochlear implantation.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668374     DOI: 10.1159/000314757

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  5 in total

1.  Systemic immunity influences hearing preservation in cochlear implantation.

Authors:  Melanie Souter; Hayden Eastwood; Paul Marovic; Gordana Kel; Sarin Wongprasartsuk; Allen F Ryan; Stephen John O'Leary
Journal:  Otol Neurotol       Date:  2012-06       Impact factor: 2.311

2.  A PLLA Coating Does Not Affect the Insertion Pressure or Frictional Behavior of a CI Electrode Array at Higher Insertion Speeds.

Authors:  Dana Dohr; Katharina Wulf; Niels Grabow; Robert Mlynski; Sebastian P Schraven
Journal:  Materials (Basel)       Date:  2022-04-22       Impact factor: 3.748

3.  Impedance Changes and Fibrous Tissue Growth after Cochlear Implantation Are Correlated and Can Be Reduced Using a Dexamethasone Eluting Electrode.

Authors:  Maciej Wilk; Roland Hessler; Kenneth Mugridge; Claude Jolly; Michael Fehr; Thomas Lenarz; Verena Scheper
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

4.  Local inner ear application of dexamethasone in cochlear implant models is safe for auditory neurons and increases the neuroprotective effect of chronic electrical stimulation.

Authors:  Verena Scheper; Roland Hessler; Mareike Hütten; Maciej Wilk; Claude Jolly; Thomas Lenarz; Gerrit Paasche
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

5.  Dexamethasone for Inner Ear Therapy: Biocompatibility and Bio-Efficacy of Different Dexamethasone Formulations In Vitro.

Authors:  Ziwen Gao; Jana Schwieger; Farnaz Matin-Mann; Peter Behrens; Thomas Lenarz; Verena Scheper
Journal:  Biomolecules       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.